Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2024Open Access

Relapse prediction in multiple myeloma patients treated with isatuximab, carfilzomib, and dexamethasone

View Full Paper
Ask AI
Bookmark
Share

Authors

EMEven Moa MyklebustSimula Research LaboratoryFSFredrik SchjesvoldOslo University HospitalAFArnoldo FrigessiOslo University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Myklebust et al. (2024) studied this question.

synapsesocial.com/papers/68e6bbccb6db64358763c219https://doi.org/10.1101/2024.05.02.24306607
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bayesian Nonlinear Models for Repeated Measurement Data: An Overview, Implementation, and Applications2022 · 25 citations
  2. 2Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation2020 · 35 citations
  3. 3Diagnosis and Management of Multiple Myeloma2022 · 1,038 citations